Research Area: HCV Care Continuum
I am a clinician scientist dedicated to improving diagnosis and care for persons with Hepatitis C Virus (HCV) infection living in resource-limited settings. I have experience in meta-analysis for diagnostic test accuracy studies, statistical analysis of large databases, and decision analytics. My research focuses on screening and diagnosis of HCV infection and seeks to inform innovative and cost-effective strategies to streamline the diagnostic algorithm and increase testing capacity in resource-limited settings to improve the care continuum.
- Published on 12/6/2017
Morgan Freiman J, Jacobson KR, Muyindike WR, Robert Horsburgh C, Ellner JJ, Hahn JA, Linas BP. Isoniazid Preventive Therapy for People with HIV who are Heavy Alcohol Drinkers in High TB/HIV Burden Countries: a Risk-Benefit Analysis. J Acquir Immune Defic Syndr. 2017 Dec 06. PMID: 29239900.
- Published on 6/21/2016
Freiman JM, Tran TM, Schumacher SG, White LF, Ongarello S, Cohn J, Easterbrook PJ, Linas BP, Denkinger CM. Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis. Ann Intern Med. 2016 Sep 06; 165(5):345-55. PMID: 27322622.
- Published on 9/3/2014
Freiman JM, Huang W, White LF, Geng EH, Hurt CB, Taylor LE, Overton ET, Cachay ER, Kitahata MM, Moore RD, Rodriguez B, Mayer KH, Linas BP. Current practices of screening for incident hepatitis C virus (HCV) infection among HIV-infected, HCV-uninfected individuals in primary care. Clin Infect Dis. 2014 Dec 15; 59(12):1686-93. PMID: 25186591.